Library / Laws / 116th Congress / House Bills / H.R. 990
H.R. 990
To amend the Federal Food, Drug, and Cosmetic Act and the Securities Exchange Act of 1934 to prevent the inter partes review process for challenging patents from diminishing competition in the pharmaceutical industry and with respect to drug innovation, and for other purposes.
| Print stage | Date | Size | ⠃ |
|---|---|---|---|
| Introduced in House | 2019-02-06 | 5.6K | ⠃⠗⠋ |